P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes-Reference-Cited by-同舟云学术

P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes

Published:2023-03-08 Issue:15 Volume:44 Page:1371-1373
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Ndrepepa Gjin¹^ORCID,Kastrati Adnan¹²^ORCID

Affiliation:

1. Klinik für Herz und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich , Germany

2. DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance , Lazarettstraße 36, D-80636, Munich , Germany

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/44/15/1371/49941826/ehad050.pdf

Reference16 articles.

1. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Collet;Eur Heart J,2021

2. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

4. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point;Ndrepepa;J Am Coll Cardiol,2008

5. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRACER) randomized trial;Valgimigli;Eur Heart J,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding;European Heart Journal;2023-04-14